Perfil
El Sr. Mark Mallon es director general y consejero de NeoGenomics Laboratories, Inc. y director general y consejero de NeoGenomics, Inc. Es miembro del Consejo de Administración de NeoGenomics Laboratories, Inc. y de NeoGenomics, Inc. Anteriormente, el Sr. Mallon fue director general y consejero de Ironwood Pharmaceuticals, Inc., presidente de Astrazeneca China Ltd., director de operaciones de Astrazeneca Japan Ltd., vicepresidente de operaciones de marketing y ventas de AstraZeneca Pharmaceuticals LP y vicepresidente ejecutivo internacional de AstraZeneca Plc. También formó parte del consejo de administración de Christiana Care Corp. Se licenció en la Universidad de Pensilvania y obtuvo un MBA en la Wharton School de la Universidad de Pensilvania.
Cargos activos de Mark Mallon
| Empresas | Cargo | Inicio |
|---|---|---|
George Medicines UK Ltd.
George Medicines UK Ltd. BiotechnologyHealth Technology Develops and commercializes drugs | Director Ejecutivo | 15/04/2024 |
Antiguos cargos conocidos de Mark Mallon.
| Empresas | Cargo | Fin |
|---|---|---|
| NEOGENOMICS, INC. | Director Ejecutivo | 28/03/2022 |
| IRONWOOD PHARMACEUTICALS, INC. | Director Ejecutivo | 12/03/2021 |
Astrazeneca China Ltd. | Presidente | 01/11/2011 |
Astrazeneca Japan Ltd.
Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Director de Operaciones | 01/04/2011 |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Presidente | - |
Formación de Mark Mallon.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 12 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
NeoGenomics, Inc.
NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Astrazeneca Japan Ltd.
Astrazeneca Japan Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical laboratories for diagnosing cancer | Health Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astrazeneca China Ltd. | |
Christiana Care Corp.
Christiana Care Corp. Hospital/Nursing ManagementHealth Services Operates as a health care organizations | Health Services |
George Medicines UK Ltd.
George Medicines UK Ltd. BiotechnologyHealth Technology Develops and commercializes drugs | Health Technology |
- Bolsa de valores
- Insiders
- Mark Mallon
















